Suven Life Sciences has secured one product patent from Israel and one product patent from Japan corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2036 and 2034 respectively. The granted claims of the patents include the class of selective M1 PAM and 5-HT4 … Read more
Jubilant Life Sciences has reported results for second quarter ended September 30, 2018. The company has reported a rise of 39.96% in its net profit at Rs 79.61 crore for the quarter under review as compared to Rs 56.88 crore for the same quarter in the previous year. Total income of the company increased by … Read more
Suven Life Sciences has secured one product patent from India and one product patent from South Korea corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029 and 2033 respectively. The granted claims of the patents include the class of selective Alpha4 … Read more
HealthCare Global Enterprises (HCG) has entered into definitive agreements providing for a business combination of its Triesta Sciences business unit (Triesta Sciences), with Strand Life Sciences, a company incorporated under the Companies Act, 1956. The company has entered into a Business Transfer Agreement (BTA), a Share Subscription Agreement (SSA) and a Shareholders’ Agreement (SHA) with … Read more
